Avanos Medical Inc (AVNS)
Days of sales outstanding (DSO)
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Receivables turnover | 4.11 | 4.82 | 5.65 | 4.16 | 4.17 | |
DSO | days | 88.72 | 75.66 | 64.60 | 87.64 | 87.59 |
December 31, 2023 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ 4.11
= 88.72
Avanos Medical Inc's Days Sales Outstanding (DSO) has shown variability over the last five years. In 2023, the DSO stood at 77.41 days, a slight increase from the previous year's 74.74 days. Comparing to 2021, there was a noticeable increase in DSO from 64.31 days, indicating a potential delay in collecting revenue from sales. However, a reduction in DSO compared to 2020 suggests an improvement in the company's collection efficiency. Despite fluctuations, maintaining DSO at a reasonable level is crucial for ensuring timely receipt of payments and managing cash flow effectively.
Peer comparison
Dec 31, 2023
Company name
Symbol
DSO
Avanos Medical Inc
AVNS
88.72
Align Technology Inc
ALGN
98.96
Edwards Lifesciences Corp
EW
47.17
Intuitive Surgical Inc
ISRG
54.16
MSA Safety
MSA
62.80
STERIS plc
STE
71.62
Zimmer Biomet Holdings Inc
ZBH
73.41